Halozyme Therapeutics Inc. Watch

from 10-Q 3 pages Amendment No. 2 to the Credit Agreement

from 8-K 19 pages Amendment No. 1 to the Credit Agreement

from 8-K 155 pages Credit Agreement Dated as of May 24, 2022 Among Halozyme Therapeutics, Inc., as the Borrower, Bank of America, N.A., as Administrative Agent, a Swing Line Lender and an L/C Issuer, and the Other Lenders and L/C Issuers Party Hereto Bofa Securities, Inc. Wells Fargo Securities, LLC, and Jpmorgan Chase Bank, N.A. as Joint Lead Arrangers and Joint Bookrunners Wells Fargo Securities, LLC, and Jpmorgan Chase Bank, N.A. as Co-Syndication Agent Bank of the West, Citibank, N.A., Goldman Sachs Bank USA, Mizuho Bank, Ltd. and Silicon Valley Bank as Co-Documentation Agents

from 8-K 120 pages Published Cusip Number: 40637kaa0 Credit Agreement Dated as of December 23, 2021 Among Halozyme Therapeutics, Inc., as the Borrower, Bank of America, N.A., as Administrative Agent, a Swing Line Lender and an L/C Issuer, and the Other Lenders Party Hereto Bofa Securities, Inc., as Sole Lead Arranger and Sole Bookrunner

from 10-Q 4 pages Third Amendment to Loan and Security Agreement

from 10-K 22 pages Consent, Release, and Second Amendment to Loan and Security Agreement

from 10-K 8 pages Consent, Release, and First Amendment to Loan and Security Agreement

from 10-Q 65 pages Loan and Security Agreement

from 10-K 67 pages Credit Agreement Dated as of December , 2015

from 10-K 7 pages Consent, Release and Third Amendment to Amended and Restated Loan and Security Agreement

from 10-K 8 pages Second Amendment to Amended and Restated Loan and Security Agreement and First Amendment to Disbursement Letter

from 10-Q 24 pages Consent and First Amendment to Amended and Restated Loan and Security Agreement

from 10-K 79 pages Amended and Restated Loan and Security Agreement

from 10-K 5 pages First Amendment to Loan and Security Agreement and Disbursement Letter

from 10-K 163 pages Loan and Security Agreement